Gingko Bioworks’ crumbling stock has been especially volatile this week.
On Monday alone the shares dropped more than 7.21 percent, while on Tuesday they rebounded 2.8 percent to close at $2.91. Unfortunately, the stock has been more than halved since February 1 and is down about 80 percent from its all-time high, making it just one of many companies that went public last year but have since collapsed in price.
One
